Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Echo Therapeutics Inc (OTCQB:ECTE)

1.07
Delayed Data
As of Jul 25
 -0.11 / -9.32%
Today’s Change
0.88
Today|||52-Week Range
2.84
-24.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues5.1K27.6K57.3K0.00
 
 
 
 
Depreciation And Amortization145.2K391.6K392.7K521.9K
 
 
 
 
 
 
Operating ExpensesGross Income-------521.9K
 
 
General Expenses14.9M19.3M12.0M7.1M
 
 
 
 
 
Research And Development8.7M11.3M5.0M2.8M
 
 
 
 
 
Total Operating Expenses15.0M19.7M12.4M7.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-15.0M-19.6M-12.3M-7.6M
 
 
 
 
 
Extraordinary Credit3.7M4.5M911.0K81.2K
 
 
 
 
 
Extraordinary Charge0.000.00---14.3M
 
 
Interest Expense On Debt959.9K3.9M3.6M15.3K
 
 
 
 
 
Other Expenses-21.3K0.00774.00-278.8K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-12.3M-19.1M-15.0M-22.2M
 
 
 
 
 
Income Taxes0.000.00-4.0K-3.4K
 
 
 
Preferred Dividend0.00-371.1K-350.0K0.00
 
 
 
Net Income-12.3M-19.1M-15.0M-22.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS4.0M8.4M12.3M11.2M
 
 
 
 
 
Shares To Calculate EPS Diluted4.0M8.4M12.3M11.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$3.10-$2.33-$1.24-$1.98
 
 
 
 
 
EPS Diluted-$3.10-$2.33-$1.24-$1.98